News
OBI's Chief Executive Officer, Heidi Wang, Ph.D. noted, "The impending OBI-902-001 clinical trial intends to evaluate the ...
A large trial showed that the weight-loss drug could reduce liver inflammation and scarring caused by the common condition ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback